Role of angiotensin receptor blockers in the prevention and management of ischaemic stroke.

about

Role of angiotensin receptor blockers in the prevention and management of ischaemic stroke.

Item

http://www.wikidata.org/entity/Q36979914

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Role of angiotensin receptor b ...... anagement of ischaemic stroke.

@en

type

Item

label

Role of angiotensin receptor b ...... anagement of ischaemic stroke.

@en

prefLabel

Role of angiotensin receptor b ...... anagement of ischaemic stroke.

@en

P1476

Role of angiotensin receptor b ...... management of ischaemic stroke

@en

P2093

E Rodrigues

http://www.w3.org/2001/XMLSchema#string

G K Davis

http://www.w3.org/2001/XMLSchema#string

G Mathur

http://www.w3.org/2001/XMLSchema#string

P2860

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes

Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack

Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group

The angiotensin type 2 receptor of angiotensin II and neuronal differentiation: from observations to mechanisms

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial--the Losartan Heart Failure Survival Study ELITE II.

The angiotensin II type 1-receptor blocker candesartan increases cerebral blood flow, reduces infarct size, and improves neurologic outcome after transient cerebral ischemia in rats.

P304

1201-1209

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1468-1331.2007.01950.X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

John Cleland

P577

2007-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17956443

http://www.w3.org/2001/XMLSchema#string